Reconstructed 1918 influenza virus induces immune response that fails to protect

NEW YORK, New York, September 27, 2006--An analysis of mice infected with the reconstructed 1918 influenza virus has revealed that although the infection triggered a very strong immune system response, the response failed to protect the animals from severe lung disease and death. The study which was published by Mount Sinai researchers, working in collaboration with scientists from the University of Washington School of Medicine in Seattle, the Centers for Disease Control and Prevention, and the Armed Forces Institute of Pathology, appeared in the online edition of Nature on September 27.

"This study gives scientists new insight into how highly pathogenic influenza viruses, such as the 1918 Spanish flu, cause disease," says Christopher F. Basler, PhD, Assistant Professor of Microbiology, who collaborated with Peter Palese, PhD, the Horace W. Goldsmith Professor and Chair of Microbiology, and also Professor of Medicine and Adolfo Garcia-Sastre, PhD, Professor of Microbiology.

Members of the research team, many of whom had collaborated on the reconstruction of the 1918 influenza virus, wanted to know why the virus, which killed 20 to 40 million people, was so lethal. In the study, researchers infected one group of mice with the reconstructed 1918 influenza virus and a second group with benign human influenza. The mice infected with the 1918 virus showed a rapid and potent immune system response, yet the animals also developed severe lung disease and died. The animals infected with the more benign viruses did not develop an immune response that was as strong, and fewer of these animals died. Genes were expressed from lung tissue samples taken from the mice, enabling the researchers to trace the immune response to each of the infections.

The potent immune system reaction of the mice infected with the 1918 virus is one of the main questions raised by the study, according to Dr. Basler. Did the very strong immune system response contribute

Contact: Mount Sinai Press Office
The Mount Sinai Hospital / Mount Sinai School of Medicine

Page: 1 2

Related biology news :

1. Reconstructed 1918 flu virus providing insights for potential pandemics
2. Detecting transmissibility of avian influenza virus in human households
3. University of Colorado licenses two influenza virus detection discoveries to Quidel Corp.
4. Avian influenza survivors antibodies effective at neutralising H5N1 strain
5. New host species for avian influenza identified
6. NIH establishes Center of Excellence for influenza research at Mount Sinai
7. U OF M awarded $22.5 million NIH contract to study avian influenza
8. A first glimpse of the influenza replication machine
9. 2,000 influenza virus genomes now completed and publicly accessible
10. Fighting influenza and co. with 40,000 blood samples
11. Changes in amino acids in the 1918 influenza virus cut transmission

Post Your Comments:

(Date:10/4/2019)... ... October 03, 2019 , ... Mount Sinai researchers have discovered how the enzyme ... generation to the next. In a study published in Nature Structural & Molecular Biology, ... leading to cancers and other diseases. , “DNA polymerase delta serves as the duplicating ...
(Date:9/30/2019)... ... September 30, 2019 , ... Foresight Institute, a ... other transformative technologies, announced the winners for the 2019 Foresight Institute Feynman Prizes. ... Theory in nanotechnology/molecular manufacturing. , Established in 1993 and named in honor of ...
(Date:9/30/2019)... Calif. (PRWEB) , ... September ... ... a leading think tank, research, and public interest organization focused on molecular ... Distinguished Student Prize. , The Award recognizes the College graduate or undergraduate ...
Breaking Biology News(10 mins):
(Date:10/10/2019)... ... October 09, 2019 , ... ... Montgomery County middle school and high school students have improved neuro-cognitive executive skills ... techniques and physical fitness, and apply lifelong social/interpersonal, leadership, problem-solving and coping skills, ...
(Date:10/8/2019)... ... October 08, 2019 , ... Today, Massachusetts stem cell biotechnology company ... technology. Like the company’s precursor patent, approved in the U.S. in 2017, the ... stem cells. Asymmetrex now markets the technology in the U.S. as the AlphaSTEM ...
(Date:10/3/2019)... ... October 02, 2019 , ... eKare’s inSight® digital 3D ... Health Accelerator run by the East Midlands Academic Health Science Network (EMAHSN), the innovation ... technology in NHS by providing support to develop and deploy solutions to the most ...
(Date:9/24/2019)... ... September 24, 2019 , ... Drug resistance has been declared as one of ... MRSA becoming one of the most serious concerns. Hong Kong cannot be spared from ... MRSA (CA-MRSA), or a seven-fold of the figure in 2007 – the year the ...
Breaking Biology Technology:
Cached News: